ArticleOncology letters2015

Anti-proliferative action of IL-6R-targeted antibody tocilizumab for non-small cell lung cancer cells.

Na-Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.